(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-08 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1532640
| Date | Daily Closing Price | Open | High | Low | Volume |
| 08 Tue Oct 2024 | 54.13 | 54.33 | 55.00 | 53.25 | 1.373 times |
| 07 Mon Oct 2024 | 53.85 | 57.92 | 57.98 | 53.32 | 1.602 times |
| 04 Fri Oct 2024 | 59.18 | 60.56 | 61.56 | 58.51 | 0.711 times |
| 03 Thu Oct 2024 | 60.43 | 58.12 | 62.00 | 57.63 | 1.212 times |
| 02 Wed Oct 2024 | 58.16 | 56.55 | 58.39 | 56.20 | 0.874 times |
| 01 Tue Oct 2024 | 56.64 | 56.97 | 57.19 | 55.89 | 0.862 times |
| 30 Mon Sep 2024 | 57.24 | 56.87 | 57.59 | 56.53 | 0.627 times |
| 27 Fri Sep 2024 | 56.97 | 57.35 | 58.04 | 56.84 | 0.786 times |
| 26 Thu Sep 2024 | 56.95 | 55.91 | 57.04 | 55.80 | 1.04 times |
| 25 Wed Sep 2024 | 55.87 | 56.50 | 56.67 | 55.43 | 0.843 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 56, but if it comes above 56, then a intra day buy could be more profitable.
If you take a sell trade below 56, then use 56 as stoploss and 52.9 as target. However if you take a buy trade in stock , then use 56 as stoploss and 58.61 as target.
Share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Target | 43.63 |
| Downside Target | 50.68 |
| Downside Target | 53.00 |
| Upside Target | 55.43 |
| Upside Target | 57.09 |
| Upside Target | 59.62 |
| Upside Target | 62.00 |
| Upside Target | 62.93 |
| Upside Target | 63.50 |
| Upside Target | 64.18 |
| Upside Target | 65.53 |
Intraday share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Intraday Target | 52.26 |
| Downside Intraday Target | 50.39 |
| Upside Intraday Target | 56.99 |
| Upside Intraday Target | 59.85 |
| Upside Intraday Target | 55.12 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 08 Tue Oct 2024 | 54.13 | 57.92 | 57.98 | 53.25 | 0.694 times |
| 04 Fri Oct 2024 | 59.18 | 56.87 | 62.00 | 55.89 | 0.901 times |
| 27 Fri Sep 2024 | 56.97 | 59.62 | 59.62 | 55.43 | 0.884 times |
| 20 Fri Sep 2024 | 59.24 | 62.78 | 63.50 | 58.71 | 1.689 times |
| 13 Fri Sep 2024 | 62.30 | 59.95 | 62.93 | 58.59 | 0.952 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 08 Tue Oct 2024 | 54.13 | 56.97 | 62.00 | 53.25 | 0.384 times |
| 30 Mon Sep 2024 | 57.24 | 63.59 | 64.18 | 55.43 | 0.887 times |
| 30 Fri Aug 2024 | 63.85 | 55.52 | 65.53 | 51.46 | 1.083 times |
| 31 Wed Jul 2024 | 55.26 | 52.23 | 57.09 | 50.68 | 0.872 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.65 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.65 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.